+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell Dissociation Market by Product, Type, Tissue, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011250
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell Dissociation Market grew from USD 759.32 million in 2023 to USD 878.60 million in 2024. It is expected to continue growing at a CAGR of 16.91%, reaching USD 2.26 billion by 2030.

Cell dissociation is the process of breaking down cellular aggregates into individual cells, crucial for various laboratory and therapeutic applications, such as tissue engineering, drug testing, and cancer research. The necessity of efficient cell dissociation techniques lies in their ability to yield high-viability cells for downstream analysis and research, crucial for the advancement of treatments and therapies. The applications of cell dissociation span numerous fields, from regenerative medicine to biotechnology, facilitating cell culture studies and the preparation of single-cell sequences. End-use industries include academic research, pharmaceutical development, and clinical diagnostics, each driving demand through their need for precise cell isolation. Key growth factors influencing the cell dissociation market include advancements in biotechnology and increasing investments in cell-based research, with significant opportunities arising in the development of automated and scalable dissociation technologies. The rising trend of personalized medicine and stem cell research further contributes by requiring efficient cell preparation techniques. Potential opportunities exist in pioneering more sustainable and less invasive cell dissociation methods, offering enhanced cell viability and yield. However, market growth is challenged by factors such as the high cost of cell-based research tools and the risk of contamination during cell separation processes. Innovations that focus on cost efficiency and minimizing contamination risks could discover significant market traction. The areas of innovation include developing novel reagents and kits that reduce the time and complexity of cell dissociation while maximizing cell yield and purity. Companies should also explore partnerships with academic institutions to advance novel technologies and applications. The cell dissociation market is characterized by competitive innovation, where maintaining a balance between cost-effectiveness and high performance is critical. Concentrated efforts on process improvement and regulatory compliance can enhance market penetration and business growth.

Understanding Market Dynamics in the Cell Dissociation Market

The Cell Dissociation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
    • Rising incidence and prevalence of chronic and infectious diseases
    • Availability of government funding for stem-cell research activities
  • Market Restraints
    • High cost of tissue and cell based procedures
  • Market Opportunities
    • Ongoing introduction of advanced cell dissociation products
    • Rising regulatory approvals for the cell dissociation developments
  • Market Challenges
    • Limited infrastructure for the cell-based research in underdeveloped countries

Exploring Porter’s Five Forces for the Cell Dissociation Market

Porter’s Five Forces framework further strengthens the insights of the Cell Dissociation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell Dissociation Market

External macro-environmental factors deeply influence the performance of the Cell Dissociation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell Dissociation Market

The Cell Dissociation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Dissociation Market

The Cell Dissociation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cell Dissociation Market

The Cell Dissociation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Enzymatic Dissociation Products
      • Collagenase
      • DNase
      • Elastase
      • Hyaluronidase
      • Papain
      • Trypsin
    • Instruments & Accessories
    • Non-Enzymatic Dissociation Products
  • Type
    • Cell Detachment
    • Tissue Dissociation
  • Tissue
    • Connective Tissues
    • Epithelial Tissues
    • Skeletal & Muscles Tissues
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
5.1.1.3. Availability of government funding for stem-cell research activities
5.1.2. Restraints
5.1.2.1. High cost of tissue and cell based procedures
5.1.3. Opportunities
5.1.3.1. Ongoing introduction of advanced cell dissociation products
5.1.3.2. Rising regulatory approvals for the cell dissociation developments
5.1.4. Challenges
5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cell Dissociation Market, by Product
6.1. Introduction
6.2. Enzymatic Dissociation Products
6.2.1. Collagenase
6.2.2. DNase
6.2.3. Elastase
6.2.4. Hyaluronidase
6.2.5. Papain
6.2.6. Trypsin
6.3. Instruments & Accessories
6.4. Non-Enzymatic Dissociation Products
7. Cell Dissociation Market, by Type
7.1. Introduction
7.2. Cell Detachment
7.3. Tissue Dissociation
8. Cell Dissociation Market, by Tissue
8.1. Introduction
8.2. Connective Tissues
8.3. Epithelial Tissues
8.4. Skeletal & Muscles Tissues
9. Cell Dissociation Market, by End-User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology Companies
9.3. Research & Academics
10. Americas Cell Dissociation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Dissociation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Dissociation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
13.3.2. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
13.3.3. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
13.3.4. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
FIGURE 2. CELL DISSOCIATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CELL DISSOCIATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL DISSOCIATION MARKET DYNAMICS
TABLE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ELASTASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HYALURONIDASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PAPAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL DISSOCIATION MARKET SIZE, BY NON-ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SKELETAL & MUSCLES TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL DISSOCIATION MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 46. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 48. CANADA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CHINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 73. CHINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. CHINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 75. CHINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 78. INDIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 80. INDIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 120. THAILAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ITALY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 164. ITALY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 166. ITALY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. POLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 184. POLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. POLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 186. POLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 189. QATAR CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. QATAR CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 191. QATAR CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cell Dissociation market, which are profiled in this report, include:
  • Abeomics Inc.
  • AcceGen
  • ACROBiosystems Group
  • ALSTEM
  • AMS Biotechnology
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biogenuix Medsystems Pvt. Ltd.
  • Capricorn Scientific
  • Captivate Bio, LLC
  • Cell Signaling Technology, Inc.
  • Cellseco Ltd.
  • Cellsystems Gmbh
  • Celprogen Corporation
  • Central Drug House. (P) Ltd.
  • Corning Inc.
  • Creative Bioarray
  • Cytori Therapeutics Inc.
  • Diagnocine
  • F. Hoffmann-La Roche Ltd.
  • FlowMetric, Inc.
  • Gemini BioProducts LLC
  • Genaxxon bioscience GmbH
  • Genlantis Inc.
  • Genomics, Inc.
  • HiMedia Laboratories Private Limited
  • Innovative Cell Technologies, Inc.
  • Krackeler Scientific, Inc.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • MP Biomedicals, LLC
  • Nacalai Tesque, Inc.
  • Neuromics
  • Nordmark Pharma GmbH
  • PAN-Biotech GmbH
  • PELOBIOTECH GmbH
  • PromoCell GmbH
  • Protein Ark Ltd. by CalibreScientific
  • REPROCELL Inc.
  • RWD Life Science Co., Ltd.
  • Sartorius AG
  • ScienCell Research Laboratories, Inc.
  • Singleron Biotechnologies GmbH
  • STEMCELL Group
  • Stemmera Inc.
  • Tebubio
  • Thermo Fisher Scientific Inc.
  • VitaCyte, LLC
  • VWR International, LLC
  • Worthington Biochemical Corporation

Methodology

Loading
LOADING...

Table Information